These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26658111)

  • 1. Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.
    Carbajo D; Magi S; Itoh M; Kawaji H; Lassmann T; Arner E; Forrest AR; Carninci P; Hayashizaki Y; Daub CO; ; Okada-Hatakeyama M; Mar JC
    PLoS One; 2015; 10(12):e0144176. PubMed ID: 26658111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells.
    Saeki Y; Endo T; Ide K; Nagashima T; Yumoto N; Toyoda T; Suzuki H; Hayashizaki Y; Sakaki Y; Okada-Hatakeyama M
    BMC Genomics; 2009 Nov; 10():545. PubMed ID: 19925682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells.
    Marek L; Levresse V; Amura C; Zentrich E; Van Putten V; Nemenoff RA; Heasley LE
    J Cell Physiol; 2004 Dec; 201(3):459-69. PubMed ID: 15389548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of receptor tyrosine kinase activation define ERK signaling dynamics.
    Kiyatkin A; van Alderwerelt van Rosenburgh IK; Klein DE; Lemmon MA
    Sci Signal; 2020 Aug; 13(645):. PubMed ID: 32817373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
    Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
    Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGF induces cell motility and multi-drug resistance gene expression in breast cancer cells.
    Garcia R; Franklin RA; McCubrey JA
    Cell Cycle; 2006 Dec; 5(23):2820-6. PubMed ID: 17172846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
    Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the calcium-sensing receptor by high calcium induced breast cancer cell proliferation and TRPC1 cation channel over-expression potentially through EGFR pathways.
    El Hiani Y; Lehen'kyi V; Ouadid-Ahidouch H; Ahidouch A
    Arch Biochem Biophys; 2009 Jun; 486(1):58-63. PubMed ID: 19332022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
    Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
    Harris LN; Yang L; Tang C; Yang D; Lupu R
    Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defined spatiotemporal features of RAS-ERK signals dictate cell fate in MCF-7 mammary epithelial cells.
    Herrero A; Casar B; Colón-Bolea P; Agudo-Ibáñez L; Crespo P
    Mol Biol Cell; 2016 Jun; 27(12):1958-68. PubMed ID: 27099370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression.
    Wang YN; Chen YJ; Chang WC
    Mol Pharmacol; 2006 Jan; 69(1):85-98. PubMed ID: 16214953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells.
    Block M; Gründker C; Fister S; Kubin J; Wilkens L; Mueller MD; Hemmerlein B; Emons G; Günthert AR
    Int J Oncol; 2012 Nov; 41(5):1845-54. PubMed ID: 22922893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XAF1 mediates apoptosis through an extracellular signal-regulated kinase pathway in colon cancer.
    Yu LF; Wang J; Zou B; Lin MC; Wu YL; Xia HH; Sun YW; Gu Q; He H; Lam SK; Kung HF; Wong BC
    Cancer; 2007 May; 109(10):1996-2003. PubMed ID: 17385215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate.
    Santos SD; Verveer PJ; Bastiaens PI
    Nat Cell Biol; 2007 Mar; 9(3):324-30. PubMed ID: 17310240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.
    Söderlund K; Pérez-Tenorio G; Stål O
    Int J Oncol; 2005 Jan; 26(1):25-32. PubMed ID: 15586221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.